Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.
By A. Wanders, D. Heijde, R. Landewé, Jéhan-Michel Béhier, A. Calin, I. Olivieri, H. Zeidler, M. Dougados. Arthritis & Rheumatism, 2005
711 citations recorded by the source corpus.
Subfields: Nephrology, Pathology and Forensic Medicine, Rheumatology
View Paper: https://www.semanticscholar.org/paper/57eef039613a331c1188f9587182a764fb778f7f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Collantes-Estévez
- E. Stanisławska-Biernat
- M. Hammoudeh
- P. Emery
- H. Boehm
- R. Berg
Citations in the corpus
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (2022, neutral): “[67-70] The task force hereby emphasises that, to date, the decision on the continuous use of NSAIDs should be based solely on the control of symptoms and not on any attempt to control structural disease progression.”
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (2011, background): “but continuous therapy may be superior in the prevention of new bone formation.”